DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20190246

The study on association of co-morbidities in female patients with vitiligo

Athilakshmi Sivasubramanian, Suchithra Ganapathi

Abstract


Background: Vitiligo is an acquired pigmentary disorder of skin characterized by the presence of depigmented patches and macules. Vitiligo has been found to be associated with certain autoimmune diseases like diabetes and hypothyroidism. This study is done to evaluate the association of certain co-morbidities with vitiligo in female patients. The aim of the study was to assess the association of vitiligo with co-morbidities in female vitiligo patients and to find the familial association.

Methods: Retrospective hospital-based study done over a period of 6 months.

Results: In this study series of 75 cases, 19% of cases were associated with hypertension, 25% were associated with diabetes mellitus, 15% were associated with hypothyroidism and positive family history was noted in 17% patients. The mean age of presentation was 43.18.

Conclusions: We found a high association of co-morbidities among female patients with vitiligo. In our study, diabetes has been found to be more commonly associated with vitiligo than other comorbidities. Hence screening for co-morbidities should be considered in vitiligo patients.


Keywords


Vitiligo, Females, Co-morbidities

Full Text:

PDF

References


Patel NS, Paghdal KV, Cohen GF. Advanced treatment for vitiligo. Dermatol Surg. 2012;38;381-91.

Viles J. Monte D, Gawkrodger DJ. Vitiligo. BMJ. 2010;341;3780.

Akay B Bozkir M, Anadolu Y. Guller S. Epidemealogy of vitiligo, associated autoimmune disease. Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venerol. 2010;24:1144-50.

Al Dain Marzouka N. SMOC 2 gene variant and the risk of vitiligo in Jordanian Arabs. Eur J Dermatol. 2010;20;701-4.

Glassman SJ. Vitiligo, reactive oxygen species and T cells. Clin Sci ( Lond). 2011;120:99-120.

Haring R, Cui J, Bystrn JC. Relation between the incidence and level of pigment antibodies and disease activity in vitiligo. J invest Dermatol. 1991;97:1078-80.

Anaya JM, Adriana JC, Richards RV, Roger PT, Levy A. The multiple Autoimmune syndromes. A clue for the Autoimmune Tautology. Clin Rev Allergy Immunol. 2012;43:256-264.

Matz H, Tur E. Vitiligo. Curr Probl Dermatol. 2007;35:78-102.

Spritz RA. The genetics of generalized vitiligo. Curr Dis Autoimmun. 2008;10:244-45.

Schimdott G, Kunsebeck HW, Jecht E. Stigmatization experience coping and sencse of coherence in vitiligo patients. J Eur Acad Dermatol Venerol Leprol. 1977;43:311-4.

Mashayekhi V, Javidi Z, Kiafer B, Manteghi AA, Saadatian V, Esmaeili HA, et al. Quality of life in patients with vitiligo. I ndian J Dermatol Venereol Leprol. 2010;76:592.

AlkhateebA, Fain PR, Thody A, Bennett DC. Epidemiology of vitiligo and associated autoimmune diseases in Caucasians. Pigment Cell Res. 2003;16;208-14.

ZhangxJ, Chen JJ, Liu JB. The genetic concept of vitiligo. J Dermatol Sci. 2005;39:137-46.

Jin Y Malloux CM, Gowank, Ricccardi SL, La Berge G, Bennett DC, et al. NALP1 in vitiligo. N Engl J Med. 2007;356:1216-25.

Zhang Z, Xu SX, Zhang FY, Yin XY, Yang S, Xiao FL, et al. The analysis of genetics and associated autoimmune diseases in vitiligo patients. Arch Dermatol Res. 2009;301:167-73.

Al–Mutairi N, Al–Sebeib KH. Late onset vitiligo and audiological abnormalities Is there any association? Indian J Dermatol Venereol Leprol. 2011;77:571-6.